Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
Supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892
A licensed clinician makes that determination based on your individual health profile
Once phosphorylated, FOXO4 translocates to the nucleusthe command center of the cell
Are we treating a medical problem, or rewriting the experience of appetite itself
At the same time, competition among manufacturers and the eventual introduction of new drug classes, including combination and multi-agonist therapies, may affect both pricing and clinical outcomes